Fizyhealth
VS Digital Health for GLP-1 plus peptide programs

Can VS Digital Health handle GLP-1 and peptide protocols for the same patient?

VS Digital Health — commonly known as VSDH — lists both GLP-1 and peptide SKUs through its branded 503A/503B pharmacy catalog, so clinics running combined weight-loss and longevity programs can source both molecule families. The evaluation for multi-protocol patients is operational: whether GLP-1 and peptide lines for the same patient checkout in one ConnectRxCare session when they route to different compounders, whether landed cost is visible on both before you quote the program, and whether validation catches SIG errors across protocols before payment.

Combined GLP-1 and peptide programs are common in weight-loss and longevity clinics. This page covers how to evaluate VSDH on multi-protocol same-patient ordering.

Compare Fizy Health vs VS Digital Health

Proudly Partnered With

Who this is for

Clinics stacking GLP-1 and peptide protocols on the same patient.

A combined-program clinic's ordering profile adds complexity: semaglutide or tirzepatide alongside sermorelin, BPC-157, or other peptides for the same patient — often routing to different 503A compounders. Three roles feel multi-protocol friction most.

  • Owners

    Founders pricing combined programs.

    Owners bundle GLP-1 with peptide adjuncts in one monthly program price. Their core question is whether landed cost on both molecule families is visible before they quote — and whether combined margin holds when each line routes differently.

  • Operators

    Staff ordering multi-protocol patient stacks.

    Ops adds GLP-1 and peptide lines for the same patient without repeating checkout when compounders differ. They need one validated cart per patient stack and validation across both protocol types before payment.

  • Prescribers

    Providers designing combined protocols.

    Prescribers pair GLP-1 titration with peptide stacks and need confidence that both SIGs reach the right pharmacies correctly. Their priority is accurate directions for both protocols handled before anything ships.

VSDH lists both GLP-1 and peptides — routing is the test

VSDH's branded pharmacy catalog includes GLP-1 compounds and peptide SKUs across 503A and 503B partners — table stakes for clinics running combined programs. Listing both families is not the differentiator; same-patient multi-protocol checkout is. GLP-1 and peptides often route to different compounders, so ask whether ConnectRxCare lets staff add both lines for one patient and pay once, or whether mixed-supplier baskets split into separate submissions.

VSDH's white-label stack fits operators launching a D2C brand that sells combined weight-loss and longevity programs through consumer apps. Existing clinics prescribing both protocols in-house evaluate ConnectRxCare on batch behavior and whether per-vial cost on GLP-1 and peptides is visible before program quotes — not blended inside revenue share.

Multi-protocol patients expose split-checkout friction

When a patient needs semaglutide from one compounder and sermorelin from another, a platform that forces separate checkouts doubles ops time and doubles rejection risk. If validation runs only at the pharmacy, a correct GLP-1 order can ship while the peptide line rejects on SIG — leaving the patient half-treated and ops chasing two statuses.

Fizy Health stacks GLP-1 and peptide lines for the same patient in one clinic cart: pass-through per-vial 503A cost visible on both before checkout, cart validation catches SIG and licensure issues across protocols before payment, and multi-pharmacy routing splits one checkout to the right compounder per line. Combined program margin stays visible on real numbers for both molecule families.

Pick the stack that matches multi-protocol ordering.

VSDH fits if

VSDH

You are launching a D2C combined GLP-1 and peptide brand on VSDH's white-label stack.

  • You need consumer apps, telemedicine, and VSDH-managed pharmacy for a greenfield combined weight-loss and longevity brand.
  • Your GLP-1 and peptide formulary is confirmed in VSDH onboarding and revenue-share economics work.
  • Per-patient multi-protocol batch cart matters less than turnkey consumer launch.
Consider Fizy Health if

Fizy Health

You stack GLP-1 and peptides for the same patient and need one validated checkout.

  • You price combined programs on per-vial GLP-1 and peptide cost visible before checkout.
  • You want GLP-1 and peptide lines for the same patient in one cart even when compounders differ.
  • You want SIG errors caught across both protocols before payment — not after partial fulfillment.
If you choose Fizy Health

What combined GLP-1 and peptide programs get from one cart.

These outcomes show up when multi-protocol patient stacks checkout once with visible margin on both molecule families.

See all features
More use-case guides

Evaluate VSDH for your clinic type.

See all use-case guides
FAQ

GLP-1 plus peptide program questions about VS Digital Health.

  • Fit

    Can VS Digital Health handle GLP-1 and peptides for the same patient?

    VS Digital Health lists both GLP-1 and peptide SKUs through its branded pharmacy catalog. Fit for combined programs depends on whether same-patient multi-protocol lines checkout in one ConnectRxCare session when compounders differ — confirm in a demo.

  • Medications

    Does VSDH offer both semaglutide and common peptides?

    VSDH's 503A/503B catalog includes GLP-1 compounds and peptide SKUs across partner pharmacies. Confirm your specific peptide strengths and GLP-1 vial sizes during onboarding.

  • Pricing

    Can I see per-vial cost on both GLP-1 and peptides before quoting a combined program?

    VSDH partner pricing is often wrapped in wholesale and revenue-share agreements rather than self-serve pass-through quotes. Fizy Health shows resolved per-vial 503A cost on GLP-1 and peptide lines before checkout.

  • Workflow

    Do GLP-1 and peptide lines split into separate checkouts on VSDH?

    Mixed-supplier baskets are a common friction point. Ask VSDH whether GLP-1 and peptide lines for one patient checkout together or require separate ConnectRxCare submissions when compounders differ.

  • Validation

    Are SIG errors caught across both protocols before payment on VSDH?

    VSDH does not publicly detail pre-submit cart validation for clinic partners. Fizy Health validates SIGs and licensure across GLP-1 and peptide lines in one cart before payment.

  • Alternative

    How does Fizy Health compare for GLP-1 plus peptide programs?

    Fizy Health stacks GLP-1 and peptide lines for the same patient in one validated cart with pass-through per-vial cost on both, multi-pharmacy routing from a single payment, and per-line HIPAA audit. VSDH fits D2C combined-program brand launches.

Sources reviewed June 2026

  • VS Digital Health public website, catalog materials, and ConnectRxCare documentation (vsdigitalhealth.com), reviewed June 2026.
  • Fizy Health platform capabilities reflect the live product.
Evaluate with real numbers

Quote combined programs on real per-vial cost for both protocols.

See landed cost on GLP-1 and peptide lines, run one validated multi-protocol cart, and decide with real numbers. Free to start.

Start Ordering FreeFizy Health vs VS Digital Health